Target intelligence / Profile preview

Lipid bicelle-to-vesicle transition (BVT)

Target
BVT
Molecular classification
Lipid assembly, Phase transition mechanism, Other
01

Overview

The lipid bicelle-to-vesicle transition is a biophysical phase transformation where discoidal lipid aggregates, known as bicelles, reorganize into closed spherical bilayers called vesicles or liposomes. This transition is typically driven by changes in environmental conditions such as temperature, dilution of short-chain surfactants, or hydration levels, which alter the edge tension and spontaneous curvature of the lipid assembly. In pharmaceutical science, this process is widely utilized in the development of advanced drug delivery systems, particularly for topical and transdermal applications. Small bicelles can penetrate the skin's stratum corneum more effectively than larger vesicles; once inside the tissue, they transition into vesicles that encapsulate and release therapeutic agents. While this mechanism is vital for 'smart' nanocarrier design and membrane protein structural studies using NMR, it represents a physical self-assembly process rather than a biological macromolecule target like a receptor or enzyme.

Other names
Bicelle-to-vesicle phase transitionBicelle-to-liposome transitionBicellar-to-vesicular transitionBVTBicelle transformation
02

Mechanism of action

Structural transformation from planar lipid discs to spherical vesicles triggered by changes in surfactant concentration, temperature, or hydration to facilitate drug encapsulation and tissue penetration.

03

Biological functions

Membrane dynamicsLipid self-assemblyPercutaneous absorption enhancementPhase transitionOther
04

Disease associations

Other
05

Safety considerations

Skin irritation potential depending on surfactant-to-lipid ratioStability of the bicellar phase during storageConsistency of transition kinetics in vivoPotential membrane disruption of non-target cells
06

Interacting drugs

Doxorubicin

5 more in the full profile.

Beyond the preview

Go deeper on Lipid bicelle-to-vesicle transition (BVT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid bicelle-to-vesicle transition (BVT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call